| PCLAX | PCLIX | PCLAX / PCLIX | |
| Total Expense Ratio | 1.22 | 0.82 | 149% |
| Annual Report Gross Expense Ratio | 1.38 | 0.98 | 141% |
| Fund Existence | 16 years | 16 years | - |
| Gain YTD | 6.292 | 6.691 | 94% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.8B | 4.8B | 100% |
| Annual Yield % from dividends | 4.54 | 4.68 | 97% |
| Returns for 1 year | 7.84 | 8.16 | 96% |
| Returns for 3 years | 14.18 | 15.60 | 91% |
| Returns for 5 years | 101.76 | 105.98 | 96% |
| Returns for 10 years | 144.21 | 154.92 | 93% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ERSMX | 28.66 | 0.04 | +0.14% |
| Eaton Vance Atlanta Capital SMID-Cap R | |||
| CGJIX | 76.33 | 0.10 | +0.13% |
| Calvert US Large Cap Growth Rspnb Idx I | |||
| JFEAX | 19.85 | 0.01 | +0.05% |
| JPMorgan Developed International Value A | |||
| VICAX | 21.61 | -0.01 | -0.05% |
| USA Mutuals Vice A | |||
| IRPSX | 10.83 | -0.16 | -1.46% |
| VY® T. Rowe Price Equity Income S | |||